Economic analysis of remote monitoring of cardiac implantable electronic devices: Results of the Health Economics Evaluation Registry for Remote Follow-up (TARIFF) study

Ricci, Renato Pietro; Vicentini, Alfredo; D’Onofrio, Antonio; Sagone, Antonio; Rovaris, Giovanni; Padeletti, Luigi; Morichelli, Loredana; Fusco, Antonio; Vivo, Stefano De; Lombardi, Leonida; Denaro, Alessandra; Pollastrelli, Annalisa; Colangelo, Irene; Santini, Massimo

doi:10.1016/j.hrthm.2016.09.008

Cited by 62 publications

(67 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, the study did not include health care provider expenses, which could impact total cost savings offered by telemedicine, such as the cost of telemedicine units (both new units and replacement of outdated or broken units), staff hourly wages (physicians, licensed nurses, IT support staff), Internet usage, and telecommunications connectivity. Previous studies have found that despite these costs to implement and maintain a telemedicine program, from the health care system perspective, telemedicine programs still remain cost-effective [22][23][24], although this may vary by specialty [25]. If additional data were made available, a more accurate picture of the environmental impact of telemedicine could be obtained.…”

Section: Discussionmentioning

confidence: 99%

Impact of a University-Based Outpatient Telemedicine Program on Time Savings, Travel Costs, and Environmental Pollutants

et al. 2017

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of a University-Based Outpatient Telemedicine Program on Time Savings, Travel Costs, and Environmental Pollutants

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Cost-utility and cost-effectiveness analyses help to quantify the value of new interventions, informing both medical decision making and public policy [24,25]. Although in the last years, economic assessments of CIEDs have increased [26][27][28][29][30][31][32][33][34], the number of cost-utility analyses used to assess outcomes in terms of utility or quality-adjusted life years (QALYs) is scarce [35], especially in PM devices [36,37], needing more health economic studies to determine the value (the relationship between additional QALYs achieved and additional costs incurred) of systematic remote monitoring in users with pacemakers.…”

Section: Introductionmentioning

confidence: 99%

Cost–utility analysis of telemonitoring versus conventional hospital-based follow-up of patients with pacemakers. The NORDLAND randomized clinical trial

et al. 2020

View full text Add to dashboard Cite

The aim of our study was to perform an economic assessment in order to check whether or not telemonitoring of users with pacemakers offers a cost-effective alternative to traditional follow-up in outpatient clinics. Methods We used effectiveness and cost data from the NORDLAND trial, which is a controlled, randomized, non-masked clinical trial. Fifty patients were assigned to receive either telemonitoring (TM; n = 25) or conventional monitoring (CM; n = 25) and were followed up for 12 months after the implantation. A cost-utility analysis was performed in terms of additional costs per additional Quality-Adjusted Life Year (QALY) attained from the perspectives of the Norwegian National Healthcare System and patients and their caregivers. Results Effectiveness was similar between alternatives (TM: 0.7804 [CI: 0.6864 to 0.8745] vs. CM: 0.7465 [CI: 0.6543 to 0.8387]), while cost per patient was higher in the RM group, both from the Norwegian NHS perspective (TM: €2,079.84 [CI: 0.00 to 4,610.58] vs. €271.97 [CI: 158.18 to 385.76]; p = 0.147) and including the patient/family perspective (TM: €2,295.91 [CI: 0.00 to 4,843.28] vs. CM: €430.39 [CI: 0.00 to 4,841.48]), although these large differences-mainly due to a few patients being hospitalized in the TM group, as opposed to none in the CM group-did not reach statistical significance. The Incremental Cost-Effectiveness Ratio (ICER) from the Norwegian NHS perspective (€53,345.27/QALY) and

show abstract

“…By applying the inclusion and exclusion criteria, the number of studies were further reduced to 37. After the full texts of 37 potentially relevant studies had been reviewed, 3 articles met the selection criteria finally, as described in Figure 1, and were included into this study (Zanaboni et al, 2013;Ricci et al, 2017; Lopez-Villegas, Catalan-Matamoros, Robles-Musso, Bautista-Mesa, & Peiro, 2018).…”

Section: Resultsmentioning

confidence: 99%

“…Zanaboni, et al found "that chronic HF patients wearing ICD/CRT-D followed with remote monitoring gained 0.066 QALYs more than those in the standard arm over the 16-month study period" (Zanaboni et al, 2013). Ricci et al reported 0.02 QALYs more were obtained from Remote Monitoring Group than Standard Care Group (Ricci et al, 2017). And Lopez-Villegas, et al put the outcome that "patients in the TM group gained 0.09 QALYs more than those in the HM group" (Lopez-Villegas et al, 2018).…”

Section: Study Outcomesmentioning

confidence: 99%

Assessment of Cost-Effectiveness on Remote Monitoring for Cardiovascular Devices in Japan

Shirane¹

2019

GJHS

View full text Add to dashboard Cite

BACKGROUND: 2018 revision of the health insurance reimbursement in Japan brought additional fee for Cardiovascular Implantable Electronic Devices (CIEDs) Management by Remote Monitoring. The adaption of CIEDs Remote Monitoring has already been recommended by the societies, but the cost-effectiveness evaluation about the system has not been enough. This research was designed, therefore, to evaluate the cost-effectiveness about CIEDs Remote Monitoring in Japan. METHODS: A systematic review was conducted along with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Certain criteria and search strategy were pre-defined to identify studies that could be included into this research. The process of the quality assessments was planned by Critical Appraisal Skills Programme (CASP). Quality Adjusted Life Years (QALYs) that were extracted from the included studies would be calculated into Incremental Cost-Effectiveness Ratio (ICER) with the reimbursement amount in Japan. RESULTS: Three studies met the systematic review criteria after the selection along with PRISMA flow diagram. The quality of the included studies was assured by CASP Checklists designed for RCT and Cohort Study. ICERs from the selected studies were provided as 569,697 JPY, 1,220,000 JPY, and 311, 111 JPY for the patient groups enrolled with Remote Monitoring system. CONCLUSION: ICERs for CIEDs Remote Monitoring were demonstrated as the cost-effective under the threshold set by Central Social Insurance Medical Council (Chuikyo). As this study put the validity of the cost-effectiveness approach in a certain field in Japan, this kind of evaluation should be performed on more areas along with the guideline by Chuikyo.

show abstract

Economic analysis of remote monitoring of cardiac implantable electronic devices: Results of the Health Economics Evaluation Registry for Remote Follow-up (TARIFF) study

Cited by 62 publications

References 23 publications

Impact of a University-Based Outpatient Telemedicine Program on Time Savings, Travel Costs, and Environmental Pollutants

Impact of a University-Based Outpatient Telemedicine Program on Time Savings, Travel Costs, and Environmental Pollutants

Cost–utility analysis of telemonitoring versus conventional hospital-based follow-up of patients with pacemakers. The NORDLAND randomized clinical trial

Assessment of Cost-Effectiveness on Remote Monitoring for Cardiovascular Devices in Japan

Contact Info

Product

Resources

About